-
-
Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.
-
-
Consumption of alcohol among women who had received primary treatment for breast cancer was not associated with increased risk of breast cancer recurrence. In fact, for non-obese patients, alcohol intake was associated with other favorable prognostic factors and improved overall survival.
-
Castleman's disease (CD), angiofollicular lymph- node hyperplasia, was initially described a half century ago in asymptomatic patients with a mediastinal mass.
-
Imatinib results in significant and durable responses for CML. The safety of discontinuation has not been rigorously tested. In a prospective study, imatinib was discontinued among CML patients in a complete molecular remission (CMR) for 2 years or more. Among 69 patients with at least one year of follow-up, 61% relapsed by molecular analysis, almost all by 6 months. After imatinib reintroduction, all 42 relapsing patients responded, of which 26 (62%) entered CMR again. High Sokal score at baseline, female sex, and shorter period of CMR predicted for relapse on imatinib discontinuation. Around 40% of patients with CML in prolonged CMR on imatinib do not relapse at least one year after stopping the drug.
-
A55-year-old woman presents to her primary physician with worsening diarrhea and abdominal discomfort. Symptoms first occurred 3 months prior to presentation, and were mild.
-
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
Extubation is defined as removal of the endotracheal tube. The decision to extubate is usually based on three considerations: 1) need for invasive respiratory support; 2) patency of the upper airway; and 3) ability to clear secretions from the lower respiratory tract.
-